AKT3 and hepatocellular carcinoma: The results showed that AKT3 overexpression in HCC cells alleviated the inhibitory effects of miR-568 mimic on stemness markers (CD133, OCT4, NANOG, and SOX-2) (Fig. 5h, Supplementary Figure S3a).